Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals ...

The real-time assessment is made possible by integrating Aiosyn’s pathology platform into Pramana’s AI edge compute ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Stem cells from the patient's healthy eye transplanted into the injured eye successfully repairing previously "irreversible" ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 ...

An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries ...

The global Liquid Biopsy Market is experiencing significant growth, driven by increasing cancer prevalence, advancements in ...

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free ...

Tethis collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer: Milan, Italy Tuesday, March 11, 2025, 13:00 Hrs [IST] Tethis S.p.A., a pioneer ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...